|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Net income | |||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||
| Depreciation | |||||
| Amortization | |||||
| Amortization of deferred debt issuance costs | |||||
| Restructuring expense, net of cash paid | |||||
| Deferred income taxes | |||||
| Pension and other postretirement benefit expenses | |||||
| Loss from equity method investments, net of dividends received | |||||
| Loss on modification of debt | |||||
| Loss on extinguishment of debt | |||||
| Term Loan A, due 2027 | |||||
| Total loss on extinguishment of debt | |||||
| (Gain) loss on sale of assets | |||||
| Goodwill impairment | |||||
| Share-based compensation | |||||
| Gain on autonomous driving joint venture, net | |||||
| Other charges related to Ukraine/Russia conflict | |||||
| Changes in operating assets and liabilities: | |||||
| Accounts receivable, net | |||||
| Inventories | |||||
| Other assets | |||||
| Accounts payable | |||||
| Accrued and other long-term liabilities | |||||
| Other, net | |||||
| Pension contributions | |||||
| Net cash provided by operating activities | |||||
| Cash flows from investing activities: | |||||
| Capital expenditures | |||||
| Proceeds from sale of property | |||||
| Proceeds from asset sale | |||||
| Proceeds from business divestitures, net of cash sold | |||||
| Cost of business acquisitions and other transactions, net of cash acquired | |||||
| Proceeds from sale of technology investments | |||||
| Cost of technology investments | |||||
| Proceeds from sale of equity method investment | |||||
| Purchase of short-term investments | |||||
| Redemption of short-term investments | |||||
| Settlement of derivatives | |||||
| Net cash used in investing activities | |||||
| Cash flows from financing activities: | |||||
| Net (repayments) proceeds under other short-term debt agreements | |||||
| Proceeds from term loans (net of $2, $0 and $0 issuance costs, respectively) | |||||
| Repayment of term loans | |||||
| Repayment of senior notes | |||||
| Proceeds from the issuance of senior and junior notes (net of $30, $0 and $22 issuance costs and $5, $0 and $6 discount, respectively) | |||||
| Proceeds from bridge loan (net of $17, $0 and $0 issuance costs, respectively) | |||||
| Payments of Financing Costs | |||||
| Repayment of bridge loan | |||||
| Equity related transaction costs | |||||
| Contingent consideration payments | |||||
| Dividend payments of consolidated affiliates to minority shareholders | |||||
| Repurchase of ordinary shares | |||||
| Distribution of mandatory convertible preferred share cash dividends | |||||
| Taxes withheld and paid on employees’ restricted share awards | |||||
| Net cash used in financing activities | |||||
| Effect of exchange rate fluctuations on cash, cash equivalents and restricted cash | |||||
| Increase (decrease) in cash, cash equivalents and restricted cash | |||||
| Cash, cash equivalents and restricted cash at beginning of the year | |||||
| Cash, cash equivalents and restricted cash at end of the year | |||||
| Payments of debt issuance costs | |||||
| Loans Payable | |||||
| Term Loan A, due 2027 | |||||
| Unamortized Loan Commitment and Origination Fees and Unamortized Discounts or Premiums | |||||
| Supplemental non-cash investing activities | |||||
| Capital expenditures included in accounts payable | |||||
| Reconciliation of cash, cash equivalents and restricted cash and cash classified as assets held for sale: | |||||
| Cash, cash equivalents and restricted cash | |||||
| Cash classified as assets held for sale | |||||
Loading...